ESR1 and breast carcinoma: A study by Kurebayashi et al. (2017) reported that, even at low concentrations (0.1 to 1 μΜ), GANT61 did not affect the growth of any of the tested breast-cancer cell lines positive for estrogen receptors, whether under estrogen deprivation or estrogen supplementation conditions.